An international team from the Hebrew University of Jerusalem (HU) and the Instituto de Microelectronica in Barcelona have developed metal iron-based biodegradable MAgnetoPlasmonic nanocapsules (MAPsules) to eradicate tumours via remote-controlled local delivery of chemotherapy at ultra-low drug concentrations. This works while also boosting drug therapeutic action and minimising damage to surrounding tissues.
To read the full article by Judy Siegel-Itzkovich on JPost, click here.